Skip to main content
Autobound logo

Eli Lilly news and events in 2026

Eli Lilly is a pharmaceutical company that develops and manufactures medicines for global distribution. The organization focuses on biotechnology, chemistry, and genetic medicine to create treatments for type two diabetes, weight loss, obstructive sleep apnea, and various forms of cancer.

Public (LLY)Pharmaceutical Manufacturing10,000+ employeeslilly.comLinkedIn

Get Eli Lilly's live signals in Claude or ChatGPT, or by API

Add to Claude / ChatGPT (MCP)Get an API key: 1,000 free credits
AskWhat changed at Eli Lilly this week? Use Autobound signals for lilly.com.
Dated updates
102
Last event
Oct 29, 2026
Open rolesSnapshot Nov 3, 2026
969
Latest SEC filing
Oct 29, 2026

Source: Autobound Signal API · 102 signals tracked for Eli Lilly · updated

Overview

Eli Lilly by topic

Latest events

Latest Eli Lilly events

All Eli Lilly news →
  1. Earnings
    Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolioEli Lilly and Company reported third-quarter 2026 net income of $6.5 billion.
    prnewswire.com
  2. In development
    After obesity, Eli Lilly is set for a big neurosciences pushEli Lilly is developing remternetug, a phase III investigational amyloid-targeting therapy for subcutaneous delivery to treat Alzheimer's disease.
    pharma.economictimes.indiatimes.com
  3. In development
    Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trialEli Lilly and Company announced positive topline results from the Phase 3 TRANSCEND-T2D-2 clinical trial evaluating retatrutide in adults with type 2 diabetes.
    prnewswire.com
  4. Promotion
    Patrik Jonsson to retire after 36 years; Ilya Yuffa named president, Lilly Global MarketsIlya Yuffa, executive vice president and president, Lilly Global Markets
    prnewswire.com
  5. In development
    New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancerEli Lilly announced clinical trial data for its investigational KRAS G12C inhibitor olomorasib in first-line KRAS G12C-mutant non-small cell lung cancer.
    prnewswire.com
  6. In development
    Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026Eli Lilly is developing sofetabart mipitecan (Sofe-M), an investigational FRα antibody-drug conjugate for ovarian cancer, announcing Phase 1 clinical trial data and testing in Phase 3 studies.
    prnewswire.com
  7. Facility expansion
    Eli Lilly Invests $5bn in VirginiaEli Lilly broke ground on a new $5 billion production facility in Goochland County, Virginia.
    marketscreener.com
  8. Executive hire
    Julia Chen Davidson joins Lilly as LillyDirect CMOJulia Chen Davidson, Senior Vice President and Chief Marketing Officer of LillyDirect
    karvtechinsider.com
  9. In development
    Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitisEli Lilly and Company reported positive Phase 3 SHINE-2 study results for Omvoh (mirikizumab-mrkz) in pediatric patients with active ulcerative colitis, meeting its primary endpoint.
    prnewswire.com
  10. Acquisition
    Eli Lilly Acquires Kelonia Therapeutics for Cancer Gene TherapyEli Lilly and Company is set to acquire Kelonia Therapeutics in a deal valued at up to $7 billion, including a $3.25 billion upfront payment.
    denkstrom.org

Showing 10 of 26 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Eli Lilly with the Signal API

One POST /v1/companies/enrich call with lilly.com returns every signal type for Eli Lilly, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"lilly.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Companies related to Eli Lilly

Eli Lilly questions

What is the latest news on Eli Lilly?
On Oct 29, 2026, prnewswire.com reported: Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio. This page tracks 26 news events for Eli Lilly since Sep 19, 2026, each with a date and a source link.
What is going on with Eli Lilly?
In the 90 days to Nov 4, 2026, Autobound tracked 26 news events, 1 10-Q filing, 1 8-K filing, 4 hiring snapshots, 1 deal, 2 executive moves, 53 signals for Eli Lilly. The newest story is from Oct 29, 2026 (Earnings), reported by prnewswire.com.
Has Eli Lilly announced any acquisitions?
The latest deal story is from Oct 5, 2026. denkstrom.org reported: Eli Lilly Acquires Kelonia Therapeutics for Cancer Gene Therapy. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for Eli Lilly?
Beyond news and filings, Autobound lists 69+ signals for Eli Lilly from 6 sources: Glassdoor (15+), LinkedIn (15+), Reddit (13), Podcasts (10), X (Twitter) (9), Patents (7). See the Eli Lilly signals page for the dated list.
Is Eli Lilly hiring right now?
Yes. As of Nov 3, 2026, Eli Lilly had 969 open roles, and Engineering had the most with 142.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →